Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10801791rdf:typepubmed:Citationlld:pubmed
pubmed-article:10801791lifeskim:mentionsumls-concept:C2247060lld:lifeskim
pubmed-article:10801791lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:10801791lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:10801791pubmed:issue29lld:pubmed
pubmed-article:10801791pubmed:dateCreated2000-8-24lld:pubmed
pubmed-article:10801791pubmed:abstractTextTo investigate the possible roles of the Ras/Rho family members in the inside-out signals to activate integrins, we examined the ability of Ras/Rho small GTPases to stimulate avidity of alpha(5)beta(1) (VLA-5) to fibronectin in bone marrow-derived mast cells. We found that both Ha-Ras(Val-12) and R-Ras(Val-38) had strong stimulatory effects on adhesion and ligand binding activity of VLA-5 to fibronectin. However, only Ha-Ras(Val-12)-, but not R-Ras(Val-38)-induced adhesion was inhibited by wortmannin, which suggests that Ha-Ras(Val-12) is dependent on phosphatidylinositol (PI) 3-kinase on adhesion whereas R-Ras(Val-38) has another PI 3-kinase independent pathway to induce adhesion. The effector loop mutant Ha-Ras(Val-12)E37G, but not Y40C retained the ability to stimulate adhesion of mast cells to fibronectin. Consistently, PI 3-kinase p110delta, predominantly expressed in mast cells, interacted with Ha-Ras(Val-12) E37G, but not Y40C, which was also correlated with the levels of Akt phosphorylation in mast cells. Furthermore, marked adhesion was induced by a membrane-targeted version of p110delta. These results indicate that Ha-Ras(Val-12) activated VLA-5 through PI 3-kinase p110delta. The mutational effects of the R-Ras effector loop region on adhesion were not correlated with PI 3-kinase activities, consistent with our contention that R-Ras has a distinct pathway to modulate avidity of VLA-5.lld:pubmed
pubmed-article:10801791pubmed:languageenglld:pubmed
pubmed-article:10801791pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10801791pubmed:citationSubsetIMlld:pubmed
pubmed-article:10801791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10801791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10801791pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10801791pubmed:statusMEDLINElld:pubmed
pubmed-article:10801791pubmed:monthJullld:pubmed
pubmed-article:10801791pubmed:issn0021-9258lld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:WatanabeSSlld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:KatagiriKKlld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:TakatsuKKlld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:Vanhaesebroec...lld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:DownwardJJlld:pubmed
pubmed-article:10801791pubmed:authorpubmed-author:KinashiTTlld:pubmed
pubmed-article:10801791pubmed:issnTypePrintlld:pubmed
pubmed-article:10801791pubmed:day21lld:pubmed
pubmed-article:10801791pubmed:volume275lld:pubmed
pubmed-article:10801791pubmed:ownerNLMlld:pubmed
pubmed-article:10801791pubmed:authorsCompleteYlld:pubmed
pubmed-article:10801791pubmed:pagination22590-6lld:pubmed
pubmed-article:10801791pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:meshHeadingpubmed-meshheading:10801791...lld:pubmed
pubmed-article:10801791pubmed:year2000lld:pubmed
pubmed-article:10801791pubmed:articleTitleDistinct mechanisms of alpha 5beta 1 integrin activation by Ha-Ras and R-Ras.lld:pubmed
pubmed-article:10801791pubmed:affiliationDepartment of Immunology, Institute of Medical Science, University of Tokyo, Tokyo 108, Bayer-chair, Japan. tkinashi@mfour.med.kyoto-u.ac.jplld:pubmed
pubmed-article:10801791pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10801791pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10801791lld:pubmed